Market Overview:
The global chemiluminescence imaging market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing demand for chemiluminescence imaging in proteomics and genomics applications. North America dominates the global chemiluminescence imaging market, followed by Europe, Asia Pacific, Latin America, and Middle East & Africa.
Product Definition:
Chemiluminescence Imaging is a technique that uses light to image chemical and biological samples. The importance of Chemiluminescence Imaging is that it allows researchers to visualize processes taking place in real time, which can help them better understand how these processes work.
Chemical for Chemiluminescence:
Chemiluminescence imaging is the application of luminescence technology in biological systems for research purposes. Chemiluminescence imaging is used to detect the presence and activity of microorganisms, such as viruses and bacteria, in a patient's body. It also helps to visualize chemical processes that take place within a living organism.
Biochemical for Bioluminescence:
Bioluminescence imaging is the use of biochemical processes for medical diagnosis. It utilizes natural light produced by the chemical reactions in order to view and examine a particular part of the human body. Bioluminescence imaging market includes products, technology, applications & services related to biochemical luminescence imaging.
Application Insights:
Proteomics application segment accounted for the largest revenue share in 2016 and is projected to continue its dominance over the forecast period. The proteomics technology is widely used for various applications such as drug discovery, biomarker discovery, disease diagnosis, and protein expression analysis. It has revolutionized the field of proteomics by providing a fast and sensitive method for detecting proteins at very low concentrations.
The genomics application segment is expected to witness substantial growth during the forecast period owing to increasing adoption of advanced technologies such as Next-generation Sequencing (NGS) that provides high Throughput & Sensitivity (T&S) at an affordable cost which makes it suitable for large scale research projects. NGS allows sequencing of entire genomes in hours instead of days which was previously possible with Sanger sequencing techniques that take weeks or months depending on DNA concentration.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a substantial number of chemiluminescence imaging-based research laboratories and hospitals. Moreover, increasing demand for advanced technologies that are used for cancer diagnosis is also expected to drive regional growth over the forecast period. Asia Pacific region is anticipated to witness lucrative growth during the forecast period due to rising healthcare expenditure by various governments and private organizations as well as growing awareness about chemiluminescence imaging in this region. In addition, increasing R&D activities related with bioluminescence technology will further propel regional growth during the forecast period.
Moreover, government initiatives such as “Make in India†initiative by Indian government has led to an increase in manufacturing facilities across various sectors including healthcare which will boost regional demand over next eight years (2018 - 2030).
Growth Factors:
- Increasing demand for chemiluminescence imaging in the life sciences sector for studying protein-protein interactions, drug discovery and development, and cell biology research.
- Growing use of chemiluminescence imaging in the diagnostics sector for detection of cancer, infectious diseases, and other medical conditions.
- Rising demand from the pharmaceutical industry for chemiluminescence imaging to develop new drugs and therapies.
- Increasing use of chemiluminescence imaging in academic research institutions to study complex biological processes at the molecular level.
Scope Of The Report
Report Attributes
Report Details
Report Title
Chemiluminescence Imaging Market Research Report
By Type
Chemical for Chemiluminescence, Biochemical for Bioluminescence, Electromagnetic as Electroluminescence, Photons as Photoluminescence, Chemiluminescence Imagin
By Application
Proteomics, Genomics, Other
By Companies
LI-COR Biosciences, Analytik Jena, Azure Biosystems, Berthold Technologies, Bio-Rad Laboratories, Cleaver Scientific, Next Advance, Syngene (SDI Group), GE Healthcare, Vilber Smart Imaging, Thermo Fisher Scientific, PerkinElmer, ANALIS, DiaSorin, Pop-Bio, UVITEC, Chemiluminescence Imagin
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global Chemiluminescence Imaging Market Report Segments:
The global Chemiluminescence Imaging market is segmented on the basis of:
Types
Chemical for Chemiluminescence, Biochemical for Bioluminescence, Electromagnetic as Electroluminescence, Photons as Photoluminescence, Chemiluminescence Imagin
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Proteomics, Genomics, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- LI-COR Biosciences
- Analytik Jena
- Azure Biosystems
- Berthold Technologies
- Bio-Rad Laboratories
- Cleaver Scientific
- Next Advance
- Syngene (SDI Group)
- GE Healthcare
- Vilber Smart Imaging
- Thermo Fisher Scientific
- PerkinElmer
- ANALIS
- DiaSorin
- Pop-Bio
- UVITEC
- Chemiluminescence Imagin
Highlights of The Chemiluminescence Imaging Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Chemical for Chemiluminescence
- Biochemical for Bioluminescence
- Electromagnetic as Electroluminescence
- Photons as Photoluminescence
- Chemiluminescence Imagin
- By Application:
- Proteomics
- Genomics
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Chemiluminescence Imaging Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Chemiluminescence imaging is a medical diagnostic technique that uses light to image the body. Chemiluminescence imaging is used to detect cancer, diagnose pregnancy, and monitor other health conditions.
Some of the major companies in the chemiluminescence imaging market are LI-COR Biosciences, Analytik Jena, Azure Biosystems, Berthold Technologies, Bio-Rad Laboratories, Cleaver Scientific, Next Advance, Syngene (SDI Group), GE Healthcare, Vilber Smart Imaging, Thermo Fisher Scientific, PerkinElmer, ANALIS, DiaSorin, Pop-Bio, UVITEC, Chemiluminescence Imagin.
The chemiluminescence imaging market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Chemiluminescence Imaging Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Chemiluminescence Imaging Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Chemiluminescence Imaging Market - Supply Chain
4.5. Global Chemiluminescence Imaging Market Forecast
4.5.1. Chemiluminescence Imaging Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Chemiluminescence Imaging Market Size (000 Units) and Y-o-Y Growth
4.5.3. Chemiluminescence Imaging Market Absolute $ Opportunity
5. Global Chemiluminescence Imaging Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Chemiluminescence Imaging Market Size and Volume Forecast by Type
5.3.1. Chemical for Chemiluminescence
5.3.2. Biochemical for Bioluminescence
5.3.3. Electromagnetic as Electroluminescence
5.3.4. Photons as Photoluminescence
5.3.5. Chemiluminescence Imagin
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Chemiluminescence Imaging Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Chemiluminescence Imaging Market Size and Volume Forecast by Application
6.3.1. Proteomics
6.3.2. Genomics
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Chemiluminescence Imaging Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Chemiluminescence Imaging Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Chemiluminescence Imaging Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Chemiluminescence Imaging Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Chemiluminescence Imaging Demand Share Forecast, 2019-2026
9. North America Chemiluminescence Imaging Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Chemiluminescence Imaging Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Chemiluminescence Imaging Market Size and Volume Forecast by Application
9.4.1. Proteomics
9.4.2. Genomics
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Chemiluminescence Imaging Market Size and Volume Forecast by Type
9.7.1. Chemical for Chemiluminescence
9.7.2. Biochemical for Bioluminescence
9.7.3. Electromagnetic as Electroluminescence
9.7.4. Photons as Photoluminescence
9.7.5. Chemiluminescence Imagin
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Chemiluminescence Imaging Demand Share Forecast, 2019-2026
10. Latin America Chemiluminescence Imaging Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Chemiluminescence Imaging Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Chemiluminescence Imaging Market Size and Volume Forecast by Application
10.4.1. Proteomics
10.4.2. Genomics
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Chemiluminescence Imaging Market Size and Volume Forecast by Type
10.7.1. Chemical for Chemiluminescence
10.7.2. Biochemical for Bioluminescence
10.7.3. Electromagnetic as Electroluminescence
10.7.4. Photons as Photoluminescence
10.7.5. Chemiluminescence Imagin
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Chemiluminescence Imaging Demand Share Forecast, 2019-2026
11. Europe Chemiluminescence Imaging Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Chemiluminescence Imaging Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Chemiluminescence Imaging Market Size and Volume Forecast by Application
11.4.1. Proteomics
11.4.2. Genomics
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Chemiluminescence Imaging Market Size and Volume Forecast by Type
11.7.1. Chemical for Chemiluminescence
11.7.2. Biochemical for Bioluminescence
11.7.3. Electromagnetic as Electroluminescence
11.7.4. Photons as Photoluminescence
11.7.5. Chemiluminescence Imagin
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Chemiluminescence Imaging Demand Share, 2019-2026
12. Asia Pacific Chemiluminescence Imaging Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Chemiluminescence Imaging Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Chemiluminescence Imaging Market Size and Volume Forecast by Application
12.4.1. Proteomics
12.4.2. Genomics
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Chemiluminescence Imaging Market Size and Volume Forecast by Type
12.7.1. Chemical for Chemiluminescence
12.7.2. Biochemical for Bioluminescence
12.7.3. Electromagnetic as Electroluminescence
12.7.4. Photons as Photoluminescence
12.7.5. Chemiluminescence Imagin
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Chemiluminescence Imaging Demand Share, 2019-2026
13. Middle East & Africa Chemiluminescence Imaging Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Chemiluminescence Imaging Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Chemiluminescence Imaging Market Size and Volume Forecast by Application
13.4.1. Proteomics
13.4.2. Genomics
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Chemiluminescence Imaging Market Size and Volume Forecast by Type
13.7.1. Chemical for Chemiluminescence
13.7.2. Biochemical for Bioluminescence
13.7.3. Electromagnetic as Electroluminescence
13.7.4. Photons as Photoluminescence
13.7.5. Chemiluminescence Imagin
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Chemiluminescence Imaging Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Chemiluminescence Imaging Market: Market Share Analysis
14.2. Chemiluminescence Imaging Distributors and Customers
14.3. Chemiluminescence Imaging Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. LI-COR Biosciences
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Analytik Jena
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Azure Biosystems
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Berthold Technologies
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Bio-Rad Laboratories
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Cleaver Scientific
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Next Advance
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Syngene (SDI Group)
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. GE Healthcare
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Vilber Smart Imaging
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Thermo Fisher Scientific
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. PerkinElmer
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. ANALIS
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. DiaSorin
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Pop-Bio
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. UVITEC
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Chemiluminescence Imagin
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
